Statins and metformin for chemoprevention of hepatocellular carcinoma

about

Statins and metformin for chemoprevention of hepatocellular carcinoma

Item

http://www.wikidata.org/entity/Q59150549

description

scientific article published on 29 August 2016

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2016

@uk

name

Statins and metformin for chemoprevention of hepatocellular carcinoma

@en

Statins and metformin for chemoprevention of hepatocellular carcinoma

@nl

type

Item

label

Statins and metformin for chemoprevention of hepatocellular carcinoma

@en

Statins and metformin for chemoprevention of hepatocellular carcinoma

@nl

prefLabel

Statins and metformin for chemoprevention of hepatocellular carcinoma

@en

Statins and metformin for chemoprevention of hepatocellular carcinoma

@nl

P1476

Statins and metformin for chemoprevention of hepatocellular carcinoma

@en

P2093

Jonggi Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Metformin and the risk of cancer: time-related biases in observational studies

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

Systematic review: Preventive and therapeutic applications of metformin in liver disease

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan.

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.

Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study.

P304

48-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLD.568

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lewis R. Roberts

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

31041062

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

6490194

http://www.w3.org/2001/XMLSchema#string